S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(2.18%) $83.12
Gas
(1.92%) $1.751
Gold
(1.78%) $2 252.10
Silver
(1.40%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.36%) $0.927
USD/NOK
(0.77%) $10.85
USD/GBP
(0.13%) $0.792
USD/RUB
(0.13%) $92.56

Realtime updates for Midatech Pharma PLC [MTPH.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated27 Mar 2023 @ 11:16

1 794.74% £ 18.00

Live Chart Being Loaded With Signals

Commentary (27 Mar 2023 @ 11:16):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally...

Stats
Today's Volume 1.38M
Average Volume 38 925.00
Market Cap 31.20M
EPS £0 ( 2023-09-12 )
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -0.220
ATR14 £3.89 (91.46%)

Volume Correlation

Long: -0.16 (neutral)
Short: -0.24 (neutral)
Signal:(10.581) Neutral

Midatech Pharma PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Midatech Pharma PLC Correlation - Currency/Commodity

The country flag -0.11
( neutral )
The country flag 0.18
( neutral )
The country flag -0.04
( neutral )
The country flag -0.35
( neutral )
The country flag 0.38
( neutral )
The country flag 0.65
( moderate )

Midatech Pharma PLC Financials

Annual 2022
Revenue: £699 000
Gross Profit: £-4.41M (-631.19 %)
EPS: £0
Q2 2018
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £0
Q2 2017
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £0
Q2 2016
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £0

Financial Reports:

No articles found.

Midatech Pharma PLC

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators